Oxidative state and IL-6 production in intestinal myofibroblasts of Crohn's disease patients

Inflammatory Bowel Diseases

Volumn 17, Issue 8, 2011, Pages 1674-1684

  Catarzi, Serena ^a   Favilli, Fabio ^a   Romagnoli, Cecilia ^a   Marcucci, Tommaso ^a   Picariello, Lucia ^a   Tonelli, Francesco ^a   Vincenzini, Maria Teresa ^a   Iantomasi, Teresa ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Crohn's disease; GSH GSSG ratio; Il 6 production; inflammatory bowel disease; oxidative state

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADULT; ARTICLE; CELL LEVEL; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINAL SUBEPITHELIAL MYOFIBROBLAST; INTESTINE CELL; MYOFIBROBLAST; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 79960258135     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21552     Document Type: Article

References (55)

1. Powell DW, Adegboyega PA, Di Mari JF, et al. Epithelial cells and their neighbors. I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Physiol Gastrointest Liver Physiol. 2005; 289: G2-G7. (Pubitemid 40944217)
2. Andoh A, Bamba S, Brittan M, et al. Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol Ther. 2007; 114: 94-106. (Pubitemid 46498158)
3. Strong SA, Pizarro TT, Klein JS, et al. Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells. Gastroenterology. 1998; 114: 1244-1256. (Pubitemid 28243911)
4. Laroux FS, Pavlick KP, Wolf RE, et al. Dysregulation of intestinal mucosal immunity: implications in inflammatory bowel disease. News Physiol Sci. 2001; 16: 272-277. (Pubitemid 33575268)
5. Coeffier M, Miralles-Barrachina O, Le Pessot F, et al. Influence of glutamine on cytokine production by human gut in vitro. Cytokine. 2001; 13: 148-154. (Pubitemid 32579303)
6. Reimund JM, Wittersheim C, Dumont S, et al. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut. 1996; 39: 684-689. (Pubitemid 26426469)
7. Theiss AL, Simmons JG, Jobin C, et al. Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J Biol Chem. 2005; 280: 36099-36109. (Pubitemid 41633881)
8. Mitsuyama K, Toyonaga A, Sasaki E, et al. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut. 1995; 36: 45-49.
9. Tamura T, Udagawa N, Takahashi N, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A. 1993; 90: 11924-11928. (Pubitemid 24008752)
10. Nishimoto N, Kishimoto T., Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol. 2006; 2: 619-626. (Pubitemid 44650950)
11. Mudter J, Neurath MF., Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis. 2007; 13: 1016-1023. (Pubitemid 47309974)
12. Keshavarzian A, Sedghi S, Kanofsky J, et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology. 1992; 103: 177-185.
13. Simmonds NJ, Allen RE, Stevens TR, et al. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology. 1992; 103: 186-196.
14. Jones DP., Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 2002; 348: 93-112. (Pubitemid 41103102)
15. Nakamura H, Nakamura K, Yodoi J., Redox regulation of cellular activation. Annu Rev Immunol. 1997; 15: 351-369. (Pubitemid 27169285)
16. Maurice MM, Nakamura H, van der Voort EA, et al. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol. 1997; 158: 1458-1465. (Pubitemid 127469974)
17. Haddad JJ., The involvement of L-gamma-glutamyl-L-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK(p38)-dependent regulation of pro-inflammatory cytokine production. Biochem Pharmacol. 2002; 63: 305-320. (Pubitemid 34158832)
18. Chaudhri G, Clark IA., Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor. J Immunol. 1989; 143: 1290-1294. (Pubitemid 19211363)
19. Iantomasi T, Marraccini P, Favilli F, et al. Glutathione metabolism in Crohn's disease. Biochem Med Metab Biol. 1994; 53: 87-91.
20. Valentich JD, Popov V, Saada JI, et al. Phenotypic characterization of an intestinal subepithelial myofibroblast cell line. Am J Physiol. 1997; 272: C1513-C1524.
21. Griffith OW., Mechanisms of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem. 1982; 257: 13704-13712. (Pubitemid 13187133)
22. Hata K, Andoh A, Shimada M, et al. IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 2002; 282: G1035-G1044. (Pubitemid 34651610)
23. Waetzig GH, Schreiber S., Review article: mitogen-activated protein kinases in chronic intestinal inflammation - targeting ancient pathways to treat modern diseases. Aliment Pharmacol Ther. 2003; 18: 17-32. (Pubitemid 36897978)
24. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's Disease Activity Index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70: 439-444.
25. Mahida YR, Galvin AM, Gray T, et al. Migration of human intestinal lamina propria lymphocytes, macrophages and eosinophils following the loss of surface epithelial cells. Clin Exp Immunol. 1997; 109: 377-386. (Pubitemid 27308428)
26. Di Sabatino A, Pender SL, Jackson CL, et al. Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology. 2007; 133: 137-149. (Pubitemid 47031137)
27. Iantomasi T, Favilli F, Degl'Innocenti D, et al. Increased glutathione synthesis associated with platelet-derived growth factor stimulation of NIH3T3 fibroblasts. Biochim Biophys Acta. 1999; 1452: 303-312.
28. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150: 76-85. (Pubitemid 16258399)
29. Duff GW, Atkins E., The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods. 1982; 52: 333-340. (Pubitemid 12044731)
30. Otte JM, Rosenberg IM, Podolsky DK., Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology. 2003; 124: 1866-1878. (Pubitemid 36666782)
31. Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975; 72: 3666-3670.
32. MÃ¥rtensson J, Jain A, Stole E, et al. Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci U S A. 1991; 88: 9360-9364. (Pubitemid 21915631)
33. Radomska-LeÅniewska DM, SkopiÅska-Rõzewska E, Jankowska-Steifer E, et al. N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients. Pharmacol Rep. 2010; 62: 131-138.
34. Sato N, Ueno T, Kubo K, et al. N-acetyl cysteine (NAC) inhibits proliferation, collagen gene transcription, and redox stress in rat palatal mucosal cells. Dent Mater. 2009; 25: 1532-1540.
35. Matsuzawa A, Ichijo H., Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta. 2008; 1780: 1325-1336.
36. Gosset P, Wallaert B, Tonnel AB, et al. Thiol regulation of the production of TNF-alpha, IL-6 and IL-8 by human alveolar macrophages. Eur Respir J. 1999; 14: 98-105. (Pubitemid 29411241)
37. Dobashi K, Aihara M, Araki T, et al. Regulation of LPS induced IL-12 production by IFN-gamma and IL-4 through intracellular glutathione state in human alveolar macrophages. Clin Exp Immunol. 2001; 124: 290-296. (Pubitemid 32587614)
38. Hashimoto S, Gon Y, Matsumoto K, et al. Intracellular glutathione regulates tumour necrosis factor-alpha-induced p38 MAP kinase activation and RANTES production by human bronchial epithelial cells. Clin Exp Allergy. 2001; 31: 144-151. (Pubitemid 32158772)
39. Chen J, Kinter M, Shank S, et al. Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production. PLoS One. 2008; 3: e3367.
40. Haddad JJ., Glutathione depletion is associated with augmenting a proinflammatory signal: evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar. Cytokines Cell Mol Ther. 2000; 6: 177-187. (Pubitemid 32834917)
41. Peristeris P, Clark BD, Gatti S, et al. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol. 1992; 140: 390-399.
42. Yagi Y, Andoh A, Inatomi O, et al. Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts. J Gastroenterol. 2007; 42: 746-753. (Pubitemid 47456762)
43. Yagi Y, Andoh A, Nishida A, et al. Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblasts. Int J Mol Med. 2007; 19: 941-946.
44. Akira S, Kishimoto T., IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev. 1992; 127: 25-50.
45. Zhong M, Cheng GF, Wang WJ, et al. Production and secretion of interleukin 6 from stimulated peritoneal macrophages of the mouse. Yao Xue Xue Bao. 1997; 32: 893-897. (Pubitemid 127463359)
46. Cicco NA, Lindemann A, Content J, et al. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood. 1990; 75: 2049-2052. (Pubitemid 20180296)
47. Sawe N, Steinberg G, Zhao H., Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res. 2008; 86: 1659-1669. (Pubitemid 351859418)
48. Schindler JF, Monahan JB, Smith WG., p38 pathway kinases as anti-inflammatory drug targets. J Dent Res. 2007; 86: 800-811.
49. Guyton KZ, Liu Y, Gorospe M, et al. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem. 1996; 271: 4138-4142.
50. Li J, Quan N, Bray TM., Supplementation of N-acetylcysteine normalizes lipopolysaccharide-induced nuclear factor kappaB activation and proinflammatory cytokine production during early rehabilitation of protein malnourished mice. J Nutr. 2002; 132: 3286-3292. (Pubitemid 35304234)
51. Rahman I., Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem Pharmacol. 2002; 64: 935-942. (Pubitemid 35232267)
52. Kanai M, Mullen C, Podolsky DK., Intestinal trefoil factor induces inactivation of extracellular signal-regulated protein kinase in intestinal epithelial cells. Proc Natl Acad Sci U S A. 1998; 95: 178-182.
53. Taupin D, Podolsky DK., Mitogen-activated protein kinase activation regulates intestinal epithelial differentiation. Gastroenterology. 1999; 116: 1072-1080. (Pubitemid 29203017)
54. Weaver CT, Harrington LE, Mangan PR, et al. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006; 24: 677-688. (Pubitemid 43867371)
55. Ito H, Takazoe M, Fukuda Y, et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology. 2004; 126: 989-999.